Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
12 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/diamyd-medical-announces-expanded-financial-support-from-breakthrough-t1d-302374634.html
13 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/diamyd-medical-updates-us-market-potential-for-diamyd-302349066.html
10 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/diamyd-medical-confirms-key-advances-toward-accelerated-approval-for-diamyd-following-fda-type-c-meeting-302347893.html
13 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/diamyd-medical-aligns-with-fda-on-key-elements-for-an-accelerated-approval-process-302331214.html
21 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/diamyd-medical-hits-a-recruitment-milestone-in-diagnode-3-phase-3-trial-302312971.html
17 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/diamyd-medical-receives-second-us-fda-fast-track-designation-for-diamyd---for-the-prevention-of-type-1-diabetes-302200410.html
ABOUT THIS PAGE
Diamyd Medical AB is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of RECOMBINANT HUMAN GLUTAMIC ACID DECARBOXYLASE (RHGAD65) bulk offered by Diamyd Medical AB